By X. Narkam. Montana State University-Northern Havre. 2019.
This is not often the case so realistically we will broadly look at factors taken into account in making a value assessment and determine what we know and where the gaps lie cheap 250 mg diamox fast delivery. The few studies included in our review suggested that some cost savings may exist cheap 250mg diamox otc, which could be substantial over time generic 250mg diamox amex. The economic information looks more favorable after the technology has been in place for an extended period of time so that the large upfront investment gets spread over time and then do we start to see a return on investment trusted diamox 250mg. However, a full economic evaluation requires the comparative analysis of alternative courses of action in terms of both costs and consequences, which provides the best information for making a decision to adopt an intervention or not, and very few of these have been rigorously completed in this field. Also, the initial expenditure and ongoing costs were rarely reported and the included cost analyses were based on projections of savings given reported changes in care processes rather than improved clinical outcomes for patients. Gains achieved by reductions in outcomes such as lengths of stay or rehospitalizations have been 716 less successful, though Durieux and colleagues do report a significant decline in hospital length of stay in a review of drug dosing decision support technologies. A number of studies 584,586,628 reported positive improvements in efficiency outcomes such as drug turnaround times, 439,600 and time to administering drugs. One study reported that nurses spent about the same time 561 on computer documentation as paper documentation. In our review, efficiencies were rarely the main endpoints of any of the studies; they were frequently reported as secondary outcomes or additional measures analyzed, but without any assessment of the power of the analysis. Because of the quality of the studies, it is difficult to attribute true productivity gains except in the cases 607 of some well-established systems as suggested by Chaudhry and colleagues. The qualitative 439,547,632 evidence indicates that stakeholders believe that gains in productivity have occurred. These studies included a number of settings and stakeholders, and most reported improvements in processes of prescribing changes, adherence to guidelines or quality measures, error reductions, preventive care procedures done, and monitoring initiated. In more than 80 percent of the cases in which an 81 improvement in process was sought, it was found to be positive. The findings of improvement were consistent across settings, levels of care, providers, and medication management phase. To balance this positive nature of the results, a growing body of evidence delineates unintended consequences of some technologies that will also contribute to the value 632,734,752 proposition of stakeholders. We reported on 78 studies that assessed clinical outcomes as their primary endpoints, the majority of which focused on prescribing and monitoring phases. However, when clinical measures were the primary endpoint, often no differences between the intervention and control groups in the higher quality studies were seen (see Table 15). We found that efficacy was greater in interventions targeting specific populations or applications. Thus, a value assessment on patient outcomes would warrant a look at specific technologies, populations, and settings beyond the scope of this report. For implementation, adoption, and ongoing use of any technology to be successful, the people using the system need to find it useful, usable, and nondisruptive. Levels of satisfaction and positive perceptions were shown to be positively correlated with measures such as ease of use, 654-657,661,673 productivity, quality of care, and reliability. When determining the proposition values, the type of technology and how well it meets expectations and workflow are important considerations for users, greatly impacting their perceptions and openness to adoption/use. Some literature has focused on comparing perceptions and attitudes of different health care 656,678 providers, such as nurses compared with physicians and trainees; and residents compared 654,657,677 with physicians using the same technologies. The type of system and how it affects health care providers’ work will impact how satisfied these stakeholders are with the technologies. For any one technology or setting, insufficient data exist to determine levels of satisfaction among all stakeholders. A focus of the greater body of research, especially commentaries and narrative reviews, is on the use of technologies to reduce medication errors. Such benefits could have repercussions on risk mitigation, but also needs to be balanced with the fact that some technologies have been shown to result in new kinds of errors. Certainly, from the literature, we see no clear understanding of what information is needed from the standpoint of each stakeholder. Hospital administrators place emphasis on other aspects such as costs, return on investment, and organizational change. The relative importance of these factors will vary among physicians practicing in different settings, with cost being more important to physicians in private practice than in hospitals, and other related issues. Similarly, the importance of these factors will vary among pharmacists depending on their practice setting and the type of technology. Work needs to be done to identify the needed critical information before we can truly assess what is missing. From the information garnered in this report, a growing body of evidence supports the use of some technologies (e. Each of the 21 articles included in this section established 800 653,789,791,793,798 evidence on likelihood to use, one on purchase, and five on implementation. A sizeable number (n = 20) of articles were on the prescribing and ordering phases, with only one 45 on the administering phase of medication management. However, the literature is sparse and evidence from studies with stronger methods that can address this question is lacking. Fundamental issues related to system characteristics included the availability and accessibility of hardware, technical support and training, system integration into clinical workflow, timeliness of clinical messages, and acceptance of the system by various 803 stakeholders. Another review involving descriptions of 112 information systems identified that for successful implementation, core components were order entry, guideline adherence, and 804 decision support. Involving end users in the development process was also shown to be a key 804 to success. Nineteen 800 articles were published in the original literature and one was from the grey literature. More than half of the studies (n = 13) evaluated 661 667 physicians as the user of the technology. One study convened a panel of technical experts 801 representing organizations having direct experience in implementing e-Prescribing standards. In most of the studies, the participants were primarily from hospitals, 791,793 45 632,653,667,798-800 and some were set in pharmacies, ambulatory care, and primary 794,795,797 48,792,796,802 care. Research methods were weak: eighteen articles were surveys, two used 801,805 qualitative research, while one used data from scientific literature, organizations, 797 government, and professional reports. Bell and colleagues conducted an expert panel consensus that resulted in 60 specific functional recommendations for e-Prescribing to improve patients’ health 806 outcomes and reduce costs. List of articles addressing various features that were instrumental in the decision to purchase, implement, and use Features Number of Studies Addressing the Features 632,653,663,789,792,794,798,799,801 Medication list 9 661,789,792,793,799 eDosing calculations 5 45,632,653,661,667,789-794,796,798-801 Clinical decision support (alerts and messages 16 for allergies, drug-drug interaction, drug approval) 48,632,653,667,790,792,794-799,802 e-Prescribing 13 45,632,792,794,798 Order communication of prescription to 5 pharmacies 45,789,790,792,794,797,799,800,802 Access to laboratory test results 9 661,789,792,795,796,799 Implementation of guidelines 6 791 Transcription services 1 653,793,795,801 Formulary information 4 45 Tallman letters and change of color to 1 differentiate between look-alike drug name pairs, 45,791,793 Integration with another system (e. Wang and colleagues suggest that mandating the use of standards is necessary but not sufficient for achieving the desired effects of e-Prescribing. Bell and colleagues evaluated two standards (Medication History Standard and Formularies and Benefits Standards) from the U. Apart from these two articles, four 45,632,663,799 other articles reported the use of commercial proprietary systems with medication management health feature sets. All the studies addressing the decision to use were based primarily on one or more of the feature sets discussed above (Table 26). Their important features were e-Prescribing, drug-drug interactions, calculation of dosing, and access to additional information. Six studies were on e-Prescribing with one being integrated with another 632 system and hand-held access. Some of the more important features addressed by these studies were e-Prescribing, medication lists, drug interaction and allergy alerts, receiving laboratory results electronically, changing doses, formularies, and order communication of prescription to 801 pharmacies. According to the study by Bell and colleagues, implementation of medication history standard and formulary and benefit standards in e-Prescribing would likely enhance usability of such systems if standard implementation was improved. Participants were dissatisfied with the unreliability of transmitting prescriptions successfully to the pharmacy, creating medication lists, recording of allergy information, and quantity of irrelevant and inappropriate alerts. Despite their complaints about alerts, participants preferred to continue receiving alerts as a safeguard against missing a major interaction. The important features were electronic connectivity for laboratory test results and orders, nursing and physician orders for medications, and prescription refills. Collectively, the important features were allergy checking, drug interactions, medication history, dosing calculation, medication formulation, and availability of laboratory test results.
Problems and some solutions in adapting clinical practice guidelines for asthma patient management into a computerised management system generic 250 mg diamox mastercard. Medical informatics in the intensive care unit: overview of technology assessment discount diamox 250 mg fast delivery. Implementation of computerized chemotherapy provider order entry in veterans affairs medical center and its role in a three tier check system buy cheap diamox 250 mg on-line. Implementation of computerized chemotherapy provider order in veterans affairs medical center and its role in the three tier check system purchase 250mg diamox with mastercard. Personal health information management and the design of consumer health information technology: Background report. A randomized comparison of a computer-based dosing program with a manual system to monitor oral anticoagulant therapy. A computer generated induction system for hospitalized patients starting on oral anticoagulant therapy. Cost effectiveness of telemedicine for the delivery of outpatient pulmonary care to a rural population. Experiences from the use of data-driven decision support in different environments. International Journal of Advanced Pervasive and Ubiquitous Computing 2009;1(3):42-60. Monatsschrift Kinderheilkunde 1993;Organ der Deutschen Gesellschaft fur Kinderheilkunde. Six generations of the insulin dosage computer: a new clinical device for diabetes self-management through specialized centres. The impact of initiatives in education, self- management training, and computer-assisted self-care on outcomes in diabetes disease management. Averting iatrogenic hypoglycemia through glucose prediction in clinical practice: Progress towards a new procedure in diabetes. Integration of a pharmacy based anticoagulation parameter into a medical group quality scorecard. Acceptability of computerized physician’s drug prescription in Grenoble Teaching Hospital, France: Survey of 44 prescribers. Electronic transmission of drug-ordering from wards to clinical pharmacies by intra or internet. Improving medication safety in a community hospital: Identifying medication errors/near misses and developing policies for high-risk medications. The effect of the controlled entry of electronic prescribing and medicines administration on the quality of prescribing, safety and success of administration on an acute medical ward. Clinical information technologies and inpatient outcomes a multiple hospital study. Electronic prescribing systems in pediatrics: the rationale and functionality requirements. Exclude - Not a Primary Study American Hospital Association, American Society of Health-System Pharmacists, Hospitals & Health Networks. Exclude - Not a Primary Study American Hospital Association, American Society of Health-System Pharmacists, Hospitals and Health Networks. Optimizing the prevention of venous thromboembolism: recent quality initiatives and strategies to drive improvement. The Effect of Electronic Prescribing on Medication Errors and Adverse Drug Events: A Systematic Review. Measuring nurses’ time in medication related tasks prior to the implementation of an electronic medication management system. Suitability of the Personal Electronic Medication profile for estimation of medication compliance. Evaluating the capability of information technology to prevent adverse drug events: a computer simulation approach. Multidisciplinary approach to decreasing the occurrence of medication errors and variances. Methods for evaluation of medication adherence and persistence using automated databases. A distributed environment for the integration of multiple high-performance decision support systems into clinical workflow. Impact of community pharmacy automation on workflow, workload, and patient interaction. Quantitative and qualitative usage data of an internet-based asthma monitoring tool. Improving guideline adherence: a randomized trial evaluating strategies to increase beta-blocker use in heart failure. Application of health informatics in the education of diabetic patients for the improvement of self-management and reporting to specialists. Journal on Information Technology in Healthcare 2008;5(6): Database: Embase Sept 22-09. Reducing lost drug charges by monitoring computer generated interdepartmental transfers. Community pharmacy, disease state management, and adherence to medication: A review. Exclude - Not a Primary Study E-42 Armstrong K S, Davis J P, Bonnell R D and others. A model and prototype for using intelligent software agents to monitor patient adherence to a medication regimen. An integrated decision support system for diagnosing and managing patients with community-acquired pneumonia. Pilot study of a Web-based compliance monitoring device for patients with congestive heart failure. Computerized checking system for drug interactions developed in Oita Medical University Hospital. Effects of computerized provider order entry and nursing documentation on workflow. The unintended consequences of computerized provider order entry: Findings from a mixed methods exploration. Effect of computer generated prompts on physician prescribing of multiple daily doses. Integration of a medication management model into outcome-based quality improvement: A pilot program in a rural proprietary home Healthcare agency. Drug-age alerting for outpatient geriatric prescriptions: a joint study using interoperable drug standards. Improving general practice computer systems for patient safety: qualitative study of key stakeholders. The role of clinical informatics technician in improving clinical pharmacy program. Tools to evaluate and implement the use of technology to decrease medication errors. Detection and incidence of drug-induced liver injuries in hospital: a prospective analysis from laboratory signals. Palliative care intervention for choice and use of opioids in the last hours of life. Journals of Gerontology - Series A Biological Sciences and Medical Sciences 2008;63(9):949-50. Improving adherence to coronary heart disease secondary prevention medication guidelines at a community hospital. A pilot study exploring the clinical benefits when using a Mobile Clinical Assistant, the Motion C5 in medical wards. Local monitoring center for clozapine therapy: Quality assurance of drug treatment in a group of psychiatric patients. Electronic communication with patients: Evaluation of distance medicine technology. Technology, governance and patient safety: Systems issues in technology and patient safety. Work practice, work processes and utopian views of automatic drug dispensing systems.
To ensure Mycobacterium tuberculosis discount 250 mg diamox fast delivery, there were 45 male patients and that results of drug susceptibility testing are reliable and accu- 37femalepatients buy 250mg diamox otc. T eagerangewasbetween16and94 rate discount diamox 250mg with amex, the standard strain H37Rv and two strains of drug resis- years old 250mg diamox with visa, with the average 53 years old. Results with resistance and multiple drug resistance were analyzed and there was not any signifcant relation between these Among 125 patients in this study, 25 samples were diagnosed parameters and resistance (Table 3). And only one patient diagnosed with berculosis antibiotics, and 14 isolates were resistant. As they received sample from Grading scale of smear positivity Sensitive Resistance value all over the country, this rate sounds highly reliable. And also in Hadizadeh and colleagues’ study in Tehran between 2006 Total 68 (100%) 14 (100%) and 2009, the resistance against isoniazid and rifampin was 11% and 10%, respectively, and 2. Tis lower rate of resistance might be due Although the grading scale of smear positivity was highly to obtaining sample from restricted regions with low rate of associated with multiple drug resistant, the relation was not resistance. On the contrary, the reported rate for resistance statistically signifcant (Table 5). Discussion and 55% resistance rate against rifampin, isoniazid, ethambu- tol, and streptomycin, respectively, as they conducted a study Nowadays, drug resistance is the main problem in controlling on 84 Mycobacterium tuberculosis isolates in Buali Hospital tuberculosis in the world. Traditionally, patients with drug resistant tuber- for tuberculosis in Zahedan (southeast of Iran) among 88 culosishavebeenassumedthatacquireddrugresistance tuberculosis cases . Te term “acquired interpreted by considering neighboring of that region with drug resistance” in patients with tuberculosis implies that Afghanistan and Pakistan as the most prevalent area for resistance has developed during treatment . BioMed Research International 5 In one study in Uzbekistan and Kazakhstan, drug resis- Te authors would like to thank Dr. A study in Pakistan during 2009–2011 showed that the resistance rate against isoniazid was 15. In this study, the  Communicable Disease Management Center, Tuberculosis resistance rate against two drugs was 20% . Considering Statistics of Iran, Ministry of Health and Medical Education, these data, our resistance rate is much lower which could be 2011. Madan, “Methicillin-resistant Staphylococcus down the increasing incidence of resistant tuberculosis and aureus and multidrug resistant tuberculosis: part 2,” Occupa- has prevented a widespread resistance in this community. Such patients ofen were treated as tuber- culosis which did not respond and categorized as treatment A. Tis means that, in addition to receiving inappropri- cellular level,” European Respiratory Journal,vol. Jawetz, Jawetz,Melnick,&Adelberg’sMedical in our study, the resistance against streptomycin was much Microbiology,McGraw-Hill,26thedition,2013. Tille, Bailey & Scott’s Diagnostic Microbiology,Mosby,13th this drug for other diseases. Conclusions “Rapid detection and species identifcation of Mycobacterium in parafn-embedded tissue by polymerase chain reaction,” As northeast of Iran is in neighborhood of Afghanistan and Diagnostic Molecular Pathology,vol. Mardani, “Drug resistant tuberculosis: a world problem,” Iranian Journal of Medical Sciences,vol. Dawoudi, “Prevalence of multidrug-resistant and extensively drug- resistant tuberculosis in patients with pulmonary tuberculosis in Zahedan, Southeastern Iran,” Iranian Red Crescent Medical Journal,vol. Alqahtani, Primary Anti-Tuberculous Drugs Resistance of Pulmonary Tuberculosis in Southwestern Saudi Arabia, Najran University, College of Medicine, Najran, Saudi Arabia, 2012. Tis is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Tese strains are cefoxitin susceptible and do not carry Staphylococcus aureus is one of the most serious pathogens of the mecAormecC genes but are characterized by oxacillin humans and important animal pathogen. Evidence for multiple, independent acquisition of the itin and oxacillin, which is conferred by acquisition of the methicillin resistance determinant of methicillin-susceptible mecAorrecentlydiscoveredmecCgene[2, 3]. One thousand aureus isolates to penicillin G (10 units/disc), cefoxitin (30 g/ and seventy-four nasal swabs were taken between 2011 and disc), tetracycline (30 g/disc), clindamycin (2 g/disc), gen- 2012 from pigs in two slaughterhouses (S1 and S2) possessing tamicin (10 g/disc), erythromycin (15 g/disc), ciprofoxacin their own meat processing plants located in south-west of (5 g/disc), norfoxacin (10 g/disc), and vancomycin Poland. Eight hundred and four nasal swabs were taken (30 g/disc) (all substances from Oxoid Ltd. Samples were collected from the nasal cavity by introducing a cotton swab for approximately 10 cm into the nares. Te notypically oxacillin-resistant isolates were analyzed for sus- isolates were identifed as S. Nasal swabs Pork meat Sampling Number of Number of Number of Number of spa types ( ) spa types ( ) samples isolates samples isolates S. Te were tested for mecC gene using the primers described bacteriumwasfoundin197(25%)fromatotalof804nasal by Cuny et al. Spa types were clustered if t034, and t091 isolated during 5 out of a total of 11 sampling cost between members of the group was less than or equal sessions (Tables 1 and 2). In contrast, genotypes t4309 and t084 4 BioMed Research International Table 2: spa types of S. Nasal swabs Pork meat Sampling Number of Number of Number of Number of spa types ( ) spa types ( ) samples isolates samples isolates S. Tis encouraged us to investigate the incidence and isolates were mecA-positiveandresistanttocefoxitininthe genotypes of S. However,itshouldbestressed were resistant to penicillin and tetracycline and susceptible that depending on sampling session it varied from 0% to 48% to gentamicin, erythromycin, ciprofoxacin, norfoxacin, and in animals and from 0 to 44% in meat indicating signifcant vancomycin. Although sporadic occurrence numerous (12%), consistently occurred in a series of sessions, of these genotypes in livestock was already noted [10, 42, what may indicate wide dissemination of this genotype in 43] isolation of these clones has been reported mainly from Poland. However, results of this survey generally frequency of these strains in Poland [25, 31]. Chambers,“Methicillinresistanceinstaphylococci:molec- and database management,” Journal of Clinical Microbiology, ular and biochemical basis and clinical implications,” Clinical vol. Witte, “Assignment of Staphylococcus isolates mosome mec: recent advances and new insights,” International to groups by spa typing, SmaI macrorestriction analysis, and JournalofMedicalMicrobiology,vol. Gutmann, “Methicillin-resistant Staphyloco- testing; twenty-second informational supplement,” Document cus aureus and vancomycin-resistant enterococci: therapeutic M100-S22, Clinical and Laboratory Standards Institute, Wayne, realities and possibilities,” Te Lancet,vol. Torriani, “Contribution of enterococci to the spread of origin, evolution and public health threat,” Trends in Microbi- antibiotic resistance in the production chain of swine meat ology, vol. Aarestrup,“spa type distribution in Staphylococcus pig farmers,” Veterinary Microbiology, vol. Zarazaga, “Detection of methicillin-resistant Staphylococcus aureus,” Infection, Genetics and Evolution,vol. Bania, “Genotypes, antibiotic resistance, and virulence factors of staphylococci from ready- to-eat food,” Foodborne Pathogens and Disease,vol. Kaiser, “Association of borderline oxacillin-susceptible strains of Staphylococcus aureus with surgical wound infections,” Jour- nal of Clinical Microbiology, vol. Daum, “Methicillin-resistant and borderline methicillin-resistant asymptomatic Staphylococcus aureus colonization in children without identifable risk factors,” Te Pediatric Infectious Disease Journal, vol. Colombo,“Molecularcharacterizationof enterotoxigenic and borderline oxacillin resistant Staphylococ- cus strains from ovine milk,” Food Microbiology,vol. Wojtyczka, Andrzej Ziwba, Arkadiusz Dziedzic, 1 1 MaBgorzata Kwpa, and Danuta Idzik 1Department and Institute of Microbiology and Virology, School of Pharmacy and Division of Laboratory Medicine in Sosnowiec, Medical University of Silesia, Jagiellonska 4, Sosnowiec, 41-200 Katowice, Poland´ 2Department of Organic Chemistry, School of Pharmacy and Division of Laboratory Medicine in Sosnowiec, Medical University of Silesia, Jagiellonska 4, Sosnowiec, 41-200 Katowice, Poland´ 3Department of Conservative Dentistry with Endodontics, Medical University of Silesia, Plac Akademicki 17, Bytom, 41-902 Katowice, Poland Correspondence should be addressed to Robert D. Tis is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Microorganisms present in diferent environments have developed specifc mechanisms of settling on various abiotic and biotic surfaces by forming a bioflm. It seems to be well justifed to search for new compounds enabling bioflm reduction, which is highly resistant to antibiotics. Te mean concentration of 4-chlorophenylamino derivative that inhibited bioflm formation was 86. Te mean concentration of 4- fuorophenylamino derivatives that inhibited bioflm formation was higher and amounted to 237. Based on the results, both derivatives of the examined compounds exhibit high antimicrobial activity towards strains growing both in planktonic and bioflm form. Tese microorganisms are ofen isolated stents, neurological ventricular shunts, surgical wounds, from nosocomial infections of the bloodstream, cardiovas- arthroprotheses, or equipment used for fracture stabilization cular system, as well as infections of the eye, ear, nose, and [2–6]. Te adhesive properties of bacteria may specialist medical procedures, including implanted objects. Bacteria connecting to the surface form micro- leading to canal formation and bioflm organization are not colonies anchored in the extracellular matrix .